Mayne Pharma Group Limited (MYX.AX)

AUD 6.98

(-0.29%)

Operating Expenses Summary of Mayne Pharma Group Limited

  • Mayne Pharma Group Limited's latest annual operating expenses in 2024 was 264.63 Million AUD , up 24.08% from previous year.
  • Mayne Pharma Group Limited's latest quarterly operating expenses in 2024 FY was 236.95 Million AUD , up 11.1% from previous quarter.
  • Mayne Pharma Group Limited reported a annual operating expenses of 213.28 Million AUD in annual operating expenses 2023, up 46.46% from previous year.
  • Mayne Pharma Group Limited reported a annual operating expenses of 145.62 Million AUD in annual operating expenses 2022, up 15.89% from previous year.
  • Mayne Pharma Group Limited reported a quarterly operating expenses of 113.15 Million AUD for 2024 Q2, down 0.0% from previous quarter.
  • Mayne Pharma Group Limited reported a quarterly operating expenses of 236.95 Million AUD for 2024 FY, up 11.1% from previous quarter.

Annual Operating Expenses Chart of Mayne Pharma Group Limited (2024 - 2007)

Historical Annual Operating Expenses of Mayne Pharma Group Limited (2024 - 2007)

Year Operating Expenses Operating Expenses Growth
2024 264.63 Million AUD 24.08%
2023 213.28 Million AUD 46.46%
2022 145.62 Million AUD 15.89%
2021 125.65 Million AUD -17.91%
2020 153.06 Million AUD -14.9%
2019 179.87 Million AUD 22.32%
2018 147.05 Million AUD 16.39%
2017 126.34 Million AUD 30.88%
2016 96.53 Million AUD 37.85%
2015 70.02 Million AUD 39.09%
2014 50.34 Million AUD 57.9%
2013 31.88 Million AUD 84.75%
2012 17.25 Million AUD -20.12%
2011 21.6 Million AUD 39.51%
2010 15.48 Million AUD 199.85%
2009 5.16 Million AUD 20.29%
2008 4.29 Million AUD 118.61%
2007 1.96 Million AUD 0.0%

Peer Operating Expenses Comparison of Mayne Pharma Group Limited

Name Operating Expenses Operating Expenses Difference
Firebrick Pharma Limited -22.78 Thousand AUD 1161679.317%